Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-16-142259

S.V.P., General Counsel sold 1,185 shares at $2.89 ($3,425)

From the SEC's structured data for this filing

Trades in this filing

Ozeroff Christopher David · S.V.P., General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-09-20 Sale : show line 1 in the form −1,185 $2.89 $3,425 18,400 D
Open-market sales · 1,185 sh · avg $2.89 · $3,425
Loading xslF345X03/doc4.xml…